The effect of rosiglitazone on integrated cardiovascular performance, cardiac structure, function and myocardial triglyceride: trial design and rationale [0.03%]
罗格列酮对心血管整体功能、心脏结构和功能以及心肌甘油三酯的影响：试验设计与原理
Darren K McGuire,Raphael See,Shuaib M Abdullah et al.
Darren K McGuire et al.
The thiazolidinedione (TZD) class of medications has been associated with increased risk for peripheral oedema, as well as incident and worsening heart failure (HF). The mechanism of these observed effects remains unclear. Here we present t...
Randomized Controlled Trial
Diabetes & vascular disease research. 2009 Jan;6(1):43-50. DOI:10.3132/dvdr.2009.009 2009
Is nuclear magnetic resonance lipoprotein subclass related to diabetic retinopathy? The multi-ethnic study of atherosclerosis (MESA) [0.03%]
核磁共振低密度脂蛋白亚型与糖尿病视网膜病变相关吗？动脉粥样硬化多种族研究(MESA)项目结果
Andreas J Kreis,Tien Yin Wong,F M Amirul Islam et al.
Andreas J Kreis et al.
Objective: To examine the associations between nuclear magnetic resonance (NMR) defined lipoproteins and diabetic retinopathy (DR) in a population-based sample of adults with type 2 diabetes. ...
Seyedeh Seddigeh Fatemi,Seyed Morteza Taghavi
Seyedeh Seddigeh Fatemi
Sexual health is an important, but often neglected, component of diabetes care. In contrast to erectile dysfunction among men with diabetes, female sexual dysfunction has not been well studied among diabetic women. The aim of this study was...
Metabolic syndrome and its single traits as risk factors for diabetes in people with impaired glucose tolerance: the STOP-NIDDM trial [0.03%]
糖耐量异常患者代谢综合征及其单个特征作为糖尿病发病危险因素的影响：STOP-NIDDM试验结果分析
Markolf Hanefeld,Avraham Karasik,Carsta Koehler et al.
Markolf Hanefeld et al.
The STOP-NIDDM trial was an international, double-blind, placebo-controlled randomised study in people with impaired glucose tolerance (IGT). They were treated with an alpha-glucosidase inhibitor, acarbose, to prevent diabetes; the overall ...
Randomized Controlled Trial
Diabetes & vascular disease research. 2009 Jan;6(1):32-7. DOI:10.3132/dvdr.2009.006 2009
Long-term hyperglycaemia impairs vascular smooth muscle cell function in women with type 1 diabetes mellitus [0.03%]
长期高血糖损害1型糖尿病女性的血管平滑肌细胞功能
Niclas Bjarnegård,Hans J Arnqvist,Torbjörn Lindström et al.
Niclas Bjarnegård et al.
Observations of increased stiffness in the elastic aorta in women with diabetes, but not men, emphasise the need for further analysis regarding early abnormalities in arterial wall properties of women with type 1 diabetes mellitus (DM). Ult...
The clinical impact of identifying metabolic syndrome in patients with diabetes: a cross-sectional study [0.03%]
糖尿病患者代谢综合征筛查的临床意义：横断面研究
Uditha Bulugahapitiya,Sajith Siyambalapitiya,Jabulani Sithole et al.
Uditha Bulugahapitiya et al.
The objectives of the study were to determine whether identifying patients with metabolic syndrome (MetS) (as defined by International Diabetes Federation [IDF] criteria) among patients with diabetes would affect the decision to prescribe s...
Circulating soluble CD36 is associated with glucose metabolism and interleukin-6 in glucose-intolerant men [0.03%]
循环可溶性CD36与糖耐量受损男性的葡萄糖代谢及白介素-6的关系
Aase Handberg,Abel Lopez-Bermejo,Judit Bassols et al.
Aase Handberg et al.
Recently, soluble CD36 (sCD36) levels were reported to be elevated in type 2 diabetes, and to be tightly correlated with insulin resistance. Our aim was to obtain further insight into the relationship between insulin sensitivity, low-grade ...
Receptor for advanced glycation end-products (RAGE) and soluble RAGE (sRAGE): cardiovascular implications [0.03%]
晚期糖基化终末产物受体(RAGE)和可溶性RAGE(sRAGE):心血管影响
Jason B Lindsey,Francesco Cipollone,Shuaib M Abdullah et al.
Jason B Lindsey et al.
Disorders of glucose metabolism are associated with increased risk for cardiovascular disease (CVD) complications, including coronary, peripheral and cerebral arterial disease, that account for the majority of morbidity and mortality among ...
Peter J Grant
Peter J Grant
Reducing residual cardiovascular risk: the relevance of raising high-density lipoprotein cholesterol in patients on cholesterol-lowering treatment [0.03%]
他汀治疗患者中升高高密度脂蛋白胆固醇以降低残余心血管风险的临床意义
Terje R Pedersen,Gerd Assmann,Jean-Pierre Bassand et al.
Terje R Pedersen et al.